Asset Details
Do you wish to reserve the book?
Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
Do you wish to request the book?
Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
2025
Overview
Smoking causes death of millions of people every year. However, available therapies for nicotine addiction are partially effective and exhibit frequent side effects. Thus vaccines targeted at drug nicotine not brain offer a promising strategy to treat nicotine addiction. They cannot pass blood-brain barrier, avoiding serious side effects relevant with central nervous system. The specific nicotine antibody produced by vaccines would convert to complex after combined with nicotine in serum, decreasing or even blocking the distribution of nicotine in brain. This review summarizes the pre-clinical and clinical advances of nicotine vaccines and then addresses future directions of nicotine vaccine and the practical aspects of deployments.
•The vaccine strategy provides a promising approach to smoking cessation.•Nicotine vaccines avoid serious side effects relevant with nervous system.•The new pre-clinical progresses greatly facilitate greater immune effectiveness.•Future directions and practical aspects of deployments were addressed.
